Cutler Group LP Amicus Therapeutics, Inc. Put Options Transaction History

Cutler Group LP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 04, 2022	SELL	$6.23 - $11.12 $623 - $1,112	-100 Closed	0 $0
Q1 2022 Apr 14, 2022	SELL	$7.89 - $12.48 $13,413 - $21,216	-1,700 Reduced 94.44%	100 $0
Q1 2021 Apr 26, 2021	SELL	$9.2 - $23.86 $186,760 - $484,358	-20,300 Reduced 91.86%	1,800 $16,000
Q4 2020 Jan 21, 2021	BUY	$13.47 - $24.89 $297,687 - $550,069	22,100 New	22,100 $9,000
Q1 2020 May 07, 2020	SELL	$6.63 - $11.16 $79,560 - $133,920	-12,000 Closed	0 $0
Q4 2019 Feb 06, 2020	SELL	$7.48 - $10.75 $85,272 - $122,550	-11,400 Reduced 48.72%	12,000 $2,000
Q1 2018 May 11, 2018	SELL	$13.76 - $17.12 $904,032 - $1.12 Million	-65,700 Reduced 73.74%	23,400 $6,000
Q4 2017 Jan 17, 2018	BUY	$12.51 - $16.24 $512,910 - $665,839	41,000 Added 85.24%	89,100 $39,000
Q3 2017 Oct 17, 2017	BUY	$11.74 - $15.78 $564,694 - $759,018	48,100	48,100 $15,000

311

312M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.7B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.